297 results on '"Vonderhaar, Barbara K."'
Search Results
2. Data from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
3. Supplementary Figure 2 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
4. Supplementary Figure 1 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
5. Supplementary Figure 4 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
6. Supplementary Figure 5 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
7. Supplementary Figure 7 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
8. Supplementary Figure 3 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
9. Supplementary Figure 9 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
10. Supplementary Figure 8 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
11. Supplementary Tables 1-4 from CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
12. Multiple New Isoforms of the Human Prolactin Receptor Gene
13. Prolactin in Human Breast Cancer Development
14. Application of In Situ PCR to Studies of the Mammary Gland
15. Whole Organ Culture of the Mouse Mammary Gland
16. Prolactin and Its Receptors in Human Breast Cancer
17. Sustained Activation of STAT5 Is Essential for Chromatin Remodeling and Maintenance of Mammary-Specific Function
18. Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP
19. Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland
20. Interdependence of Hormones and Growth Factors in Lobulo-Alveolar Development of the Mammary Gland and in Tumorigenesis
21. Intramammary Delivery of Hormones, Growth Factors, and Cytokines
22. Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer
23. Phospholipid Methylation Stimulates Lactogenic Binding in Mouse Mammary Gland Membranes
24. Membrane Modification Differentially Affects the Binding of the Lactogenic Hormones Human Growth Hormone and Ovine Prolactin
25. Purification of a Prolactin Receptor
26. Lactose Synthetase Activity in Mouse Mammary Glands Is Controlled by Thyroid Hormones
27. A Role of the Cell Cycle in Hormone-Dependent Differentiation
28. Some Aspects of Mouse Mammary Gland Development from Maturity to Early Pregnancy
29. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells
30. Up-Regulation of MSX2 Enhances the Malignant Phenotype and Is Associated with Twist 1 Expression in Human Pancreatic Cancer Cells
31. 16-kDa Prolactin Reduces Angiogenesis, but Not Growth of Human Breast Cancer Tumors In Vivo
32. Historical Perspectives of Prolactin and Growth Hormone as Mammogens, Lactogens and Galactagogues—Agog for the Future!
33. Additional file of Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
34. Additional file 3 of Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
35. Additional file 1 of Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
36. Additional file 2 of Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
37. Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3
38. Msx-1 and Msx-2 in Mammary Gland Development
39. Expression of functional prolactin and its receptor in human colorectal cancer
40. Establishing a Framework for the Functional Mammary Gland: From Endocrinology to Morphology
41. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas
42. Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors
43. Prolactin-induced expression of vascular endothelial growth factor via Egr-1
44. Prolactin as a Mitogen in Mammary Cells
45. Activation ofraf-1, MEK, and MAP kinase in prolactin responsive mammary cells
46. Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment
47. Unmodified Prolactin (PRL) and S179D PRL-Initiated Bioluminescence Resonance Energy Transfer between Homo- and Hetero-Pairs of Long and Short Human PRL Receptors in Living Human Cells
48. Role of Human Cripto-1 in Tumor Angiogenesis
49. Local Insulin-Like Growth Factor-II Mediates Prolactin-Induced Mammary Gland Development
50. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.